2023
DOI: 10.3389/fonc.2023.1147668
|View full text |Cite
|
Sign up to set email alerts
|

A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer

Abstract: Triple-negative breast cancer (TNBC) is known as the most difficult molecular subtype of breast cancer to treat. Recent studies revealed that cancer stem cells (CSCs) play a critical role in TNBC recurrence and metastasis. In this study, we developed a recombinant replication-deficient adenoviral vector (Ad-CD44-N-HIF-3α4), which contains a gene encoding a synthetic Notch (synNotch) receptor composed of the extracellular domain of CD44 (CD44-ECD) and the hypoxia-inducible factor (HIF)-3α4 connected by the Notc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 62 publications
0
1
0
Order By: Relevance
“…Likewise, the intranasal administration of Advs allows high transduction efficiency in the lung, thus it has been proposed to treat lung metastases [ 78 ]. Recently, an Adv encoding for a hypoxia-inducible factor (HIF)-3α4 and CD44 decoy protein system that is activated by Notch ligands has demonstrated efficacy in murine models of human TNBC subtypes [ 79 ]. Here, we observed robust transduction efficiency of Ad.dTomato and Ad.P60 in murine BRCA cells both in vitro and in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…Likewise, the intranasal administration of Advs allows high transduction efficiency in the lung, thus it has been proposed to treat lung metastases [ 78 ]. Recently, an Adv encoding for a hypoxia-inducible factor (HIF)-3α4 and CD44 decoy protein system that is activated by Notch ligands has demonstrated efficacy in murine models of human TNBC subtypes [ 79 ]. Here, we observed robust transduction efficiency of Ad.dTomato and Ad.P60 in murine BRCA cells both in vitro and in vivo.…”
Section: Discussionmentioning
confidence: 99%